— Know what they know.
Not Investment Advice
Also trades as: IF0.DE (XETRA) · $vol 0M

IFRX NASDAQ

InflaRx N.V.
1W: +7.8% 1M: -8.8% 3M: +0.6% YTD: +52.3% 1Y: +18.6% 3Y: -17.0% 5Y: -40.1%
$1.66
+0.09 (+5.40%)
 
Weekly Expected Move ±9.5%
$1 $1 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 42 · $244.6M mcap · 126M float · 0.727% daily turnover · Short 38% of daily vol
Credit Risk of going bust: lower than 66% of companies Debt: 0.4% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), InflaRx N.V. would be worth roughly what it owes.
Total debt $927K against a stock market value of $244.6M.
Distance to default 6.92 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $303K (short-term plus half of long-term), stock volatility 91.4%; Altman Z'' 3.85. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
⛈️
Stormy
-20.8% YTD avg
Midterm Year
☀️
Sunny
+15.4% YTD avg
2026 Now
☀️
Sunny
Above typical
20yr Avg YTD
-20.8%
Day 206 of 252
Midterm Year YTD
+15.4%
Presidential cycle avg
2026 YTD
+52.3%
Above 20yr avg
Typical Vol
91%
Annualized
Monthly Weather Forecast
Jan
20yr
⛈️
-2.5%
Midterm
☁️
+0.3%
22% win 72% vol
Feb
20yr
⛈️
-5.0%
Midterm
⛈️
-6.0%
56% win 90% vol
Mar
20yr
⛈️
-15.6%
Midterm
⛈️
-8.6%
33% win 106% vol
Apr
20yr
💨
+17.9%
Midterm
☀️
+21.0%
67% win 164% vol
May
20yr
⛈️
+11.0%
Midterm
☀️
+11.0%
33% win 108% vol
Jun
20yr
⛈️
-16.8%
Midterm
🌧️
-4.1%
22% win 151% vol
Jul
20yr
💨
-16.6%
Midterm
☀️
+5.2%
33% win 74% vol
Aug
20yr
💨
-13.3%
Midterm
☀️
+7.3%
44% win 80% vol
Sep
20yr
⛈️
-19.1%
Midterm
☀️
+14.4%
33% win 70% vol
Oct
20yr
💨
-23.0%
Midterm
☀️
+6.0%
44% win 91% vol
Now: -7.8%
Nov
20yr
💨
-18.1%
Midterm
⛅
+4.5%
56% win 93% vol
Dec
20yr
💨
+8.5%
Midterm
💨
+21.9%
67% win 91% vol
Seasonality (20yr)
Updated: 2026-10-27
YTD: +52.3%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms